BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 15534088)

  • 1. Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology.
    Kracht LW; Miletic H; Busch S; Jacobs AH; Voges J; Hoevels M; Klein JC; Herholz K; Heiss WD
    Clin Cancer Res; 2004 Nov; 10(21):7163-70. PubMed ID: 15534088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.
    Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K
    J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography in the diagnosis of recurrent growth of brain tumors].
    Skvortsova TIu; Brodskaia ZL; Rudas MS; Mozhaev SV; Gurchin AF; Medvedev SV
    Zh Vopr Neirokhir Im N N Burdenko; 2005; (2):3-7; discussion 7. PubMed ID: 16078626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fractional anisotropy for determination of the cut-off value in 11C-methionine positron emission tomography for glioma.
    Kinoshita M; Hashimoto N; Goto T; Yanagisawa T; Okita Y; Kagawa N; Kishima H; Tanaka H; Fujita N; Shimosegawa E; Hatazawa J; Yoshimine T
    Neuroimage; 2009 Apr; 45(2):312-8. PubMed ID: 19111621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.
    Lilja A; Lundqvist H; Olsson Y; Spännare B; Gullberg P; Långström B
    Acta Radiol; 1989; 30(2):121-8. PubMed ID: 2493795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional imaging of cortical structure, function and glioma for tumor resection.
    Nariai T; Senda M; Ishii K; Maehara T; Wakabayashi S; Toyama H; Ishiwata K; Hirakawa K
    J Nucl Med; 1997 Oct; 38(10):1563-8. PubMed ID: 9379193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [11C-methionine PET, IMP-SPECT, CT and MRI in brain tumors].
    Schober O; Creutzig H; Meyer GJ; Becker H; Schwarzrock R; Dietz H; Hundeshagen H
    Rofo; 1985 Aug; 143(2):133-6. PubMed ID: 2992024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced accuracy in differential diagnosis of radiation necrosis by positron emission tomography-magnetic resonance imaging coregistration: technical case report.
    Thiel A; Pietrzyk U; Sturm V; Herholz K; Hövels M; Schröder R
    Neurosurgery; 2000 Jan; 46(1):232-4. PubMed ID: 10626957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.
    Martorana G; Schiavina R; Corti B; Farsad M; Salizzoni E; Brunocilla E; Bertaccini A; Manferrari F; Castellucci P; Fanti S; Canini R; Grigioni WF; D'Errico Grigioni A
    J Urol; 2006 Sep; 176(3):954-60; discussion 960. PubMed ID: 16890665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies.
    Pirotte B; Goldman S; Massager N; David P; Wikler D; Lipszyc M; Salmon I; Brotchi J; Levivier M
    J Neurosurg; 2004 Sep; 101(3):476-83. PubMed ID: 15352606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.
    Toyohara J; Nariai T; Sakata M; Oda K; Ishii K; Kawabe T; Irie T; Saga T; Kubota K; Ishiwata K
    J Nucl Med; 2011 Aug; 52(8):1322-8. PubMed ID: 21764794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differential diagnosis of brain gliomas by positron emission tomography using various radiopharmaceuticals].
    Kostenikov NA; Tiutin LA; Fadeev NP; Panfilenko AF; Zykov EM; Iliushchenko IuR; Makeeva OIu
    Vestn Rentgenol Radiol; 2014; (5):13-8. PubMed ID: 25775890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.